-- 全球風能理事會(GWEC)週一表示,受中東衝突和霍爾木茲海峽關閉加速再生能源轉型的影響,預計到2025年,全球風能裝置容量將新增165吉瓦,累計裝置容量將超過1.3太瓦。 GWEC在一份報告中指出,風電裝置容量的成長主要得益於對陸上風電的強勁需求,陸上風電裝置容量成長42%至155.3吉瓦,而離岸風電裝置容量則成長18%至9吉瓦。 報告稱,以中國和印度為首的亞洲新增裝置容量達131吉瓦,佔全球總量的80%。全球風能理事會(GWEC)表示,中國在全球風電成長中佔據主導地位,預計2025年新增風電裝置容量將達到約120.5吉瓦,幾乎與2024年全球新增裝置容量持平。 受《通膨削減法案》的撤銷和離岸風電租賃的暫時取消的影響,風電行業正面臨巨大的「逆風」。儘管美國風電產業面臨政策上的嚴重分歧,但該國去年仍新增了約7吉瓦的陸上風電裝置容量。 GWEC表示,人工智慧資料中心和製造業不斷增長的需求將使風電繼續成為美國電網的重要組成部分,儘管其地位也存在政治爭議。 GWEC指出,新興市場也在加速風電裝置容量的成長,沙烏地阿拉伯的裝置容量成長了四倍,達到1.5吉瓦;智利成長了三倍,達到1.1吉瓦;土耳其達到2.1吉瓦,這反映出風電在各地區的戰略吸引力正在不斷擴大。 同時,各國政府日益將風能視為增強經濟韌性的工具,而不僅僅是應對氣候變遷的手段。全球風能理事會(GWEC)表示,風能如今在能源安全、可用性、可及性、可負擔性和可接受性這四大支柱方面均有所建樹,因為它能降低對波動性能源進口的依賴。 報告指出,風能產業也在不斷發展。人工智慧和先進的數據分析技術如今已成為整個價值鏈的標配,涵蓋從資源評估到機組優化等各個環節。 此外,風能、太陽能和儲能結合的「混合」專案的興起,也展現了該產業如何穩定發電量並提升整體系統性能。 GWEC預測,到2026年,新增裝置容量將達到178吉瓦,未來五年預計總裝置容量將達到969吉瓦。 為實現《巴黎協定》提出的2030年將再生能源裝置容量增加兩倍的目標,報告指出,各國政府必須專注於三大成功要素:穩定的政策框架、高效的許可審批和協調的電網規劃。
Related Articles
Biocytogen Pharmaceuticals Turns to Profit in Q1
Biocytogen Pharmaceuticals (Beijing) (HKG:2315) recorded an attributable profit of 104 million yuan in the first quarter of 2026, compared with an attributable loss of 13.2 million yuan a year prior, according to a Monday Hong Kong bourse filing.Earnings per share stood at 0.23 yuan, compared with a loss per share of 0.03 yuan in the corresponding period of the previous fiscal year.Operating revenue jumped 74% in the three months to 433.1 million yuan from 249.3 million yuan in the year-ago period, driven by a substantially higher revenue contribution from pharmacology and efficacy services and animal models.The pharmaceutical company attributed the higher profit mainly to revenue growth and improved operating efficiency amid expense management.
Market Chatter: LNG Carrier Orders Surge as Global Output Defies Iran War Tensions
Global demand for liquefied natural gas carriers is rebounding sharply in 2026, despite the ongoing US-Iran conflict, Reuters reported Monday, citing analysts and industry experts.Analysts report that surging LNG production and a transition toward high-efficiency vessels are fueling the recovery.According to the report, Shipbuilders in South Korea and China have already secured 35 new build contracts in Q1 alone.The resurgence in construction comes despite the escalating US-Iran war, which has choked the Strait of Hormuz and raised fears of a prolonged shipping downturn.However, market experts suggest that the need for modern, fuel-efficient tonnage is outweighing immediate freight rate concerns, it said.These new vessels, which cost between $250 million and $260 million and take over three years to complete, are increasingly necessary as older, steam-propelled tankers are scrapped at record rates to meet stricter global emissions regulations.(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)
Canaccord Genuity Initiates Coverage on Structure Therapeutics With Buy Rating, $101 Price Target
Structure Therapeutics (GPCR) has an average rating of Buy and mean price target of $108.50, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)